Currencies / EXEL
EXEL: Exelixis Inc
36.94
USD
1.23
(3.22%)
EXEL exchange rate has changed by -3.22% for today. During the day, the instrument was traded at a low of 36.81 and at a high of 38.44.
Follow Exelixis Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
EXEL News
- Zacks 2 Highly Ranked Stocks to Consider After Q2 Earnings: CLS, EXEL
- Investor's Business Daily Seagate Soars To Record High, Steps Into Spotlight: Find Best Stocks To Buy And Watch On The IBD 50, Big Cap 20 And Other Lists
- Investing UnitedHealth, Eli Lilly Lead Market Cap Stock Movers on Tuesday
- Investing Exelixis stock price target lowered to $45 at RBC on lifecycle cuts
- Investing Truist Securities lowers Exelixis stock price target to $49 on mixed results
- Investing Exelixis stock price target raised to $41 from $38 at Stifel on NET launch
- Benzinga Exelixis Stuns Analyst With Q2 Miss, Trial Delays, Phase 3 Halt - Exelixis (NASDAQ:EXEL)
- Zacks All You Need to Know About Exelixis (EXEL) Rating Upgrade to Strong Buy
- Investing Eli Lilly, UnitedHealth among Tuesday’s market cap stock movers
- Zacks EXEL Q2 Earnings Top, Sales Miss on Lower Collaboration Revenues
- Benzinga Whirlpool Posts Downbeat Earnings, Joins Harmonic, Stanley Black & Decker And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Fulcrum Therapeutics (NASDAQ:FULC), Exelixis (NASDAQ:EXEL)
- Investor's Business Daily Stock Market Today: Dow Feels The Most Pain, Nasdaq Struggles; Spotify Surprises Investors (Live Coverage)
- Investing Exelixis fall over 12% after revenue miss, halts zanzalintinib trial
- Investing Exelixis stock rating reiterated by JMP analyst despite sales miss
- Seeking Alpha Exelixis, Inc. (EXEL) Q2 2025 Earnings Call Transcript
- Investing Earnings call transcript: Exelixis beats EPS forecasts in Q2 2025
- The Motley Fool Exelixis Q2 Revenue Falls 11 Percent
- Investing After-hours movers: Western Union, Whirlpool, Exelixis, and more
- Zacks Exelixis (EXEL) Beats Q2 Earnings Estimates
- Investing Exelixis shares tumble as revenue miss and weak guidance disappoint
- Investing Exelixis earnings beat by $0.11, revenue fell short of estimates
- Zacks Here's Why Exelixis (EXEL) is a Strong Momentum Stock
- Investor's Business Daily Dow Jones Futures Loom as Trump-EU Trade Deal Reached; Tesla 'Robotaxis' In Focus With Earnings Wave Ahead
- Investor's Business Daily Dow Jones Futures: Meta, Amazon, Fed, Trump Tariffs Ahead; Tesla Robotaxi Or Just Taxi?
Daily Range
36.81
38.44
Year Range
23.21
49.40
- Previous Close
- 44.39
- Open
- 38.17
- Bid
- 36.94
- Ask
- 37.24
- Low
- 36.81
- High
- 38.44
- Volume
- 43.957 K
- Daily Change
- -3.22%
- Month Change
- -16.10%
- 6 Months Change
- 12.55%
- Year Change
- 58.27%
30 July, Wednesday
12:15
USD
- Act
- 104 K
- Fcst
- 57 K
- Prev
- -33 K
12:30
USD
- Act
- 3.0%
- Fcst
- 0.4%
- Prev
- -0.5%
12:30
USD
- Act
- 2.0%
- Fcst
- 3.6%
- Prev
- 3.8%
12:30
USD
- Act
- 2.5%
- Fcst
- 3.3%
- Prev
- 3.5%
12:30
USD
- Act
- 2.1%
- Fcst
- 3.1%
- Prev
- 3.7%
12:30
USD
- Act
- 1.4%
- Fcst
- 0.8%
- Prev
- 0.5%
12:30
USD
- Act
- 6.3%
- Fcst
- -1.5%
- Prev
- -3.1%
14:00
USD
- Act
- Fcst
- 1.6%
- Prev
- 1.8%
14:00
USD
- Act
- Fcst
- 9.6%
- Prev
- 1.1%
14:00
USD
- Act
- Fcst
- Prev
- 72.6
14:30
USD
- Act
- Fcst
- 0.914 M
- Prev
- -3.169 M
14:30
USD
- Act
- Fcst
- 0.114 M
- Prev
- 0.455 M
14:30
USD
- Act
- Fcst
- 0.738 M
- Prev
- -0.740 M
14:30
USD
- Act
- Fcst
- -0.004 M
- Prev
- 0.095 M
14:30
USD
- Act
- Fcst
- -0.111 M
- Prev
- 2.931 M
14:30
USD
- Act
- Fcst
- 0.915 M
- Prev
- 0.282 M
14:30
USD
- Act
- Fcst
- 0.608 M
- Prev
- 0.003 M
14:30
USD
- Act
- Fcst
- 0.879 M
- Prev
- -1.738 M
14:30
USD
- Act
- Fcst
- Prev
- 0.087 M
14:30
USD
- Act
- Fcst
- Prev
- 1.6%
18:00
USD
- Act
- Fcst
- Prev
18:00
USD
- Act
- Fcst
- Prev
- 4.50%
18:30
USD
- Act
- Fcst
- Prev